These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20663842)

  • 1. De novo infantile primary antiphospholipid antibody syndrome.
    Alshekaili J; Reynolds G; Cook MC
    Lupus; 2010 Nov; 19(13):1565-8. PubMed ID: 20663842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of infantile de novo primary antiphospholipid syndrome revealed by a neonatal arterial ischemic stroke.
    Merlin E; Doré E; Chabrier S; Biard M; Marques-Verdier A; Stéphan JL
    J Child Neurol; 2012 Oct; 27(10):1340-2. PubMed ID: 23007300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study.
    Motta M; Chirico G; Rebaioli CB; Faden D; Lojacono A; Allegri F; Migliori C; Tincani A
    Am J Perinatol; 2006 May; 23(4):247-51. PubMed ID: 16625500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
    Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P
    Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
    Ali HY; Abdullah ZA
    J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anti-beta 2-glycoprotein I antibodies.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y; Twig G; Katz U; Sherer Y
    J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid syndrome in children.
    Avcin T
    Curr Opin Rheumatol; 2008 Sep; 20(5):595-600. PubMed ID: 18698184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistency of low levels of anticardiolipin and anti-beta2 glycoprotein1 in thrombosis.
    Amaral M; Favas C; Delgado Alves J
    Eur J Intern Med; 2010 Apr; 21(2):101-3. PubMed ID: 20206880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.